|
Connexin 43 and Osteopontin Expression
in Human Melanoma Cells
Lauren Palmer, Carrie Paquette-Straub, and Mary E. Miele
Department of Medical Technology
The gene that encodes connexin 43 (CX43), a gap junctional protein,
is located on chromosome 6 in a region (6q16.3-q23) frequently deleted
in malignant melanomas. Changes in gap junctional activity have been implicated
in tumor progression. Thus, we hypothesize that CX43 may play a role
in the regulation of human melanoma metastasis. More specifically,
we proposed that increased CX43 expression may decrease metastatic potential
in melanoma cells. In a panel of highly metastatic human melanoma cell
lines RT-PCR revealed that these cell lines expressed little or no CX43
mRNA. To test our hypothesis, CX43 (i.e., CX43pcDNA3.1/hygromycin) is being
transfected into two human metastatic melanoma cell lines, MelJuSo and
M24met. Frequently, CX43 expression is inversely correlated with osteopontin
(OPN) levels, a secreted integrin-binding protein. Other investigators
have reported that OPN is overexpressed in tumors when compared to normal
tissue and is prominent at sites of tumor invasion and necrosis. Furthermore,
increased OPN levels have been found in the blood of patients with metastatic
cancers, such as colon, breast, prostate, lung, and stomach. These findings
led us to assay several melanoma cell lines for OPN expression. RT-PCR
demonstrated that nine human metastatic melanoma cell lines expressed varying
levels of OPN. CX43 transfected melanoma cells will be evaluated for gap
junctional activity and metastatic ability in nude mice in future experiments. |